12

A leading inhalation expert

Iconovo develops new inhaled medicinal products in collaboration with international pharmaceutical companies. The company offers several types of patented dry powder inhaler devices, and inhouse formulation, for the development of inhalation products within both new pharmaceuticals and generic medicine. As a leading inhaler expert, Iconovo is the knowledgeable partner you need to accelerate opportunities and time to market.

Latest news from Iconovo

Anders Månsson at DNB Carnegie Småbolagsdag

Iconovo’s new Interim CEO, Anders Månsson, made his first official appearance for the company when he presented Iconovo at DNB Carnegie’s Småbolagsdag…
Read more

Iconovo carries out a directed issue of shares of approx. SEK 25 million and a rights issue of shares of approx. SEK 24.6 million

The Board of Directors of Iconovo AB ("Iconovo" or the "Company") has today resolved on a directed share issue of approximately SEK 25 million (the…
Read more

Iconovo appoints Anders Månsson as new CEO

Iconovo AB (publ), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, has today appointed Anders…
Read more
Read all news

Meet us

BUSINESS MEETINGS

BIO-Europe Spring 2026

March 23-25, 2026

Lisbon, Portugal

DCAT Week

March 23-26, 2026

New York City, USA

RRD 2026

May 10-24, 2026

Phoenix, Arizona, USA

BIO International 2026

June 22-25, 2026

San Diego, USA

INVESTOR MEETINGS

PARTNERSHIP

Your innovative inhaler partner

We are a leading inhalation company that develops inhalation products in our patented, innovative inhalers, supporting customers in bringing their inhaled treatments to market.

Learn more

PRODUCTS

Five differentiated technical platforms

We develop inhaled medicines from your drug substance as your complete inhalation partner. We take you all the way through your pharmaceutical product development, from idea to finalized inhalation product. Our strength is the integrated development of inhaler and dry powder formulation. Four differentiated technical inhaler platforms can be optimized with your unique dry powder formulation, and we also assist with manufacturing of clinical trial material in early clinical trials and technical documentation for registrations.

Learn more

DEVELOPMENT RESOURCES

Engineering and pharmaceutical expertise

Iconovo has an integrated development process, with all competences and facilities inhouse. With a unique combination of engineering and pharmaceutical expertise, our capabilities include devices, formulation, pharmaceutical analysis, and advisory services.

Learn more

Stay up to date with Iconovo’s news and press releases

SIGN UP